![(2E)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methylidene]undecanoic acid](https://static.cymitquimica.com/cas-image/325727-2e-2-45-dimethoxy-2-methyl-36-dioxocyclohexa-14-dien-1-yl-methylidene-undecanoic-acid.png)
CAS: 136164-66-4 - (2E)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methylidene]undecanoic acid
Formula:C21H30O6
InChI:InChI=1S/C21H30O6/c1-5-6-7-8-9-10-11-12-15(21(24)25)13-16-14(2)17(22)19(26-3)20(27-4)18(16)23/h13H,5-12H2,1-4H3,(H,24,25)/b15-13+
InChI key:InChIKey=AALSSIXXBDPENJ-FYWRMAATSA-N
SMILES:O=C(O)C(=CC=1C(=O)C(OC)=C(OC)C(=O)C1C)CCCCCCCCC
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | E3330 REF: TM-T6823CAS: 136164-66-4 | 98.83% | 50.00 €~1,476.00 € | Wed 22 May 24 |
 | E3330 REF: 3D-LFA16466CAS: 136164-66-4 | Min. 95% | To inquire | Tue 02 Jul 24 |
E3330
CAS:136164-66-4
E3330 is a potent and selective APE1(Ref-1) inhibitor, which suppressed NF-kappa B DNA-binding activity.
Formula:
C21H30O6
Purity:
98.83%
Color and Shape:
Solid
Molecular weight:
378.46
Ref: TM-T6823
| 1mg | 50.00 € | |
| 2mg | 71.00 € | |
| 5mg | 105.00 € | |
| 10mg | 170.00 € | |
| 25mg | 297.00 € | |
| 50mg | 492.00 € | |
| 100mg | 708.00 € | |
| 200mg | 998.00 € | |
| 500mg | 1,476.00 € | |
| 1ml*10 (DMSO) | 87.00 € |
Estimated delivery in United States, on Wednesday 22 May 2024
E3330
CAS:136164-66-4
E3330 is a drug that has been shown to have anti-tumor activity in experimental models. …
Formula:
C21H30O6
Purity:
Min. 95%
Molecular weight:
378.46 g/mol
Ref: 3D-LFA16466
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024
